African Journal of
Biotechnology

  • Abbreviation: Afr. J. Biotechnol.
  • Language: English
  • ISSN: 1684-5315
  • DOI: 10.5897/AJB
  • Start Year: 2002
  • Published Articles: 12487

Full Length Research Paper

Why bacteria derived R-M nucleic enzymatic peptides are likely efficient therapeutic molecules for use in the design and development of novel HIV inhibitory strategies

Wayengera Misaki
Makerere University, Faculty of Medicine, Kampala, Uganda.
Email: [email protected]

  •  Accepted: 19 October 2007
  •  Published: 17 June 2008

How to cite this article

APA /
Misaki, W. (2008). Why bacteria derived R-M nucleic enzymatic peptides are likely efficient therapeutic molecules for use in the design and development of novel HIV inhibitory strategies. African Journal of Biotechnology , 7(12), 1791-1796.
Chicago /
Wayengera Misaki. "Why bacteria derived R-M nucleic enzymatic peptides are likely efficient therapeutic molecules for use in the design and development of novel HIV inhibitory strategies." African Journal of Biotechnology 7, no. 12 (2008): 1791-1796.
MLA /
Wayengera Misaki. "Why bacteria derived R-M nucleic enzymatic peptides are likely efficient therapeutic molecules for use in the design and development of novel HIV inhibitory strategies." African Journal of Biotechnology 7.12 (2008): 1791-1796.
DOI /
https://doi.org/10.5897/AJB07.516
URL /
https://academicjournals.org/journal/AJB/article-abstract/A00D27F6999

Copyright © 2024 Author(s) retain the copyright of this article.

This article is published under the terms of the Creative Commons Attribution License 4.0

Back to Vol. 7 No. 12
Back to articles
  • Articles on Google by:
SUBSCRIBE TO RSS
SUBMIT MANUSCRIPT
CONFERENCES